Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36442116.
- Also identified by DOI 10.1073/pnas.2203454119 and PMC identifier 7614094.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The development of innate lymphoid cell (ILC) transcription factor reporter mice has shown a previously unexpected complexity in ILC hematopoiesis. Using novel polychromic mice to achieve higher phenotypic resolution, we have characterized bone marrow progenitors that are committed to the group 1 ILC lineage. These common ILC1/NK cell progenitors (ILC1/NKP), which we call "aceNKPs", are defined as lineage<sup>-</sup>Id2<sup>+</sup>IL-7Rα<sup>+</sup>CD25<sup>-</sup>α4β7<sup>-</sup>NKG2A/C/E<sup>+</sup>Bcl11b<sup>-</sup>. In vitro, aceNKPs differentiate into group 1 ILCs, including NK-like cells that express Eomes without the requirement for IL-15, and produce IFN-γ and perforin upon IL-15 stimulation. Following reconstitution of <i>Rag2<sup>-/-</sup>Il2rg<sup>-/-</sup></i> hosts, aceNKPs give rise to a spectrum of mature ILC1/NK cells (regardless of their tissue location) that cannot be clearly segregated into the traditional ILC1 and NK subsets, suggesting that group 1 ILCs constitute a dynamic continuum of ILCs that can develop from a common progenitor. In addition, aceNKP-derived ILC1/NK cells effectively ameliorate tumor burden in a model of lung metastasis, where they acquired a cytotoxic NK cell phenotype. Our results identify the primary ILC1/NK progenitor that lacks ILC2 or ILC3 potential and is strictly committed to ILC1/NK cell production irrespective of tissue homing.
Medical subject headings
- Interleukin-15
- Immunity, Innate